Pulmonary rehabilitation in idiopathic pulmonary fibrosis and COPD: a propensity matched real-world study
File(s)1-s2.0-S0012369221042082-main.pdf (517.17 KB)
Published version
Author(s)
Type
Journal Article
Abstract
BACKGROUND: The adherence to and clinical efficacy of pulmonary rehabilitation in idiopathic pulmonary fibrosis (IPF), particularly in comparison to people with chronic obstructive pulmonary disease (COPD), remains uncertain. The objectives of this real-world study were to compare the responses of patients with IPF with a matched group of patients with COPD undergoing the same supervised, outpatient pulmonary rehabilitation program, and to determine whether pulmonary rehabilitation is associated with survival in IPF. RESEARCH QUESTION: Do people with IPF improve to the same extent with pulmonary rehabilitation as a matched group of individuals with COPD, and are non-completion of and/or non-response to pulmonary rehabilitation associated with one-year all-cause mortality in IPF? STUDY DESIGN AND METHODS: Using propensity score matching, 163 patients with IPF were matched 1:1 with a control group of 163 patients with COPD referred to pulmonary rehabilitation. We compared between-group pulmonary rehabilitation completion rates and response. Survival status in the IPF cohort was recorded over one-year following pulmonary rehabilitation discharge. Cox proportional-hazards regression explored the association between pulmonary rehabilitation status and all-cause mortality. RESULTS: Similar pulmonary rehabilitation completion rates (IPF: 69%; COPD: 63%; p=0.24) and improvements in exercise response were observed in both groups with no significant mean (95% confidence interval (CI)) between-group differences in incremental shuttle walk (ISW) change (2 (-18 to 22) meters). Pulmonary rehabilitation non-completion (hazard ratio (HR) (95%CI) 5.62 (2.24 to 14.08)) and non-response (HR (95%CI) 3.91 (1.54 to 9.93)) were independently associated with increased one-year all-cause mortality in IPF. INTERPRETATION: Compared with a matched group of patients with COPD, this real-word study demonstrates that patients with IPF have similar completion rates and magnitude of response to pulmonary rehabilitation. In IPF, non-completion of and non-response to pulmonary rehabilitation were associated with increased all-cause mortality. These data reinforce the benefits of pulmonary rehabilitation in patients with IPF.
Date Issued
2022-03-04
Date Acceptance
2021-10-07
Citation
Chest, 2022, 161 (3), pp.728-737
ISSN
0012-3692
Publisher
American College of Chest Physicians (ACCP)
Start Page
728
End Page
737
Journal / Book Title
Chest
Volume
161
Issue
3
Copyright Statement
© 2021 Published by Elsevier Inc under license from the American College of Chest Physicians. The Journal Pre-proof is available open access under a CC-BY-NC-ND Licence (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Sponsor
National Institute for Health Research
British Lung Foundation
Action for Pulmonary Fibrosis
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/34699771
PII: S0012-3692(21)04208-2
Grant Number
CS-2013-13-017
C17-3
n/a
Subjects
COPD
Idiopathic pulmonary fibrosis
prognosis
pulmonary rehabilitation
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2021-10-23